Opdivo

February 8, 2017 at 11:48 pm

Keytruda and Opdivo to Vie Head On in Japan

The Ministry of Welfare disclosed February 8 at the meeting of the Central Social Insurance Medical Council the market price of Keytruda, a cancer drug developed by the US pharmaceutical firm Merck & Co. at 39,099 yen per day or 14 million yen per year.

November 23, 2016 at 8:08 pm

Super Cancer Drug Down-Priced 50%

The Welfare-Labor Minister's advisory body, the Central Social Insurance Medical Council, agreed to bring down the price of the revolutionary cancer drug Opdivo by 50%, effective February, next year.